These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30377918)

  • 1. Specific Tumor Characteristics Predict Upstaging in Early-Stage Esophageal Cancer.
    Haisley KR; Hart CM; Kaempf AJ; Dash NR; Dolan JP; Hunter JG
    Ann Surg Oncol; 2019 Feb; 26(2):514-522. PubMed ID: 30377918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
    Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.
    Semenkovich TR; Panni RZ; Hudson JL; Thomas T; Elmore LC; Chang SH; Meyers BF; Kozower BD; Puri V
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2221-2230.e1. PubMed ID: 29428700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.
    Samson P; Puri V; Robinson C; Lockhart C; Carpenter D; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Crabtree T
    Ann Thorac Surg; 2016 Jun; 101(6):2102-11. PubMed ID: 27083246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival.
    Crabtree TD; Yacoub WN; Puri V; Azar R; Zoole JB; Patterson GA; Krupnick AS; Kreisel D; Meyers BF
    Ann Thorac Surg; 2011 May; 91(5):1509-15; discussion 1515-6. PubMed ID: 21435632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical T2 N0 M0 Esophageal Cancer: Identifying Predictive Factors of Upstaging.
    Tasnim S; Raja S; Blackstone EH; Toth AJ; Barron JO; Raymond DP; Bribriesco AC; Schraufnagel DP; Murthy SC; Sudarshan M
    Ann Thorac Surg; 2024 Jun; 117(6):1121-1127. PubMed ID: 38307482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Pathologic Upstaging in cT1b Esophageal Cancer: Should We Consider Neoadjuvant Therapy?
    Mann DR; Engelhardt KE; Gibney BC; Batten ME; Klipsch EC; Mukherjee R; Bostock IC
    J Surg Res; 2024 Mar; 295():61-69. PubMed ID: 37992454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of pathologic upstaging in early esophageal adenocarcinoma: Results from the national cancer database.
    Brown CS; Gwilliam N; Kyrillos A; Lutfi W; Lapin B; Kim KW; Krantz SB; Howington JA; Yao K; Ujiki MB
    Am J Surg; 2018 Jul; 216(1):124-130. PubMed ID: 28802729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic factors associated with pathologic upstaging in patients clinically diagnosed stage T2N0M0 squamous cell esophageal carcinoma.
    Li M; Xie H; Zhen F; Wang H; Peng Z; Xu L
    J Cancer Res Ther; 2020 Sep; 16(5):1106-1111. PubMed ID: 33004755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation.
    Coker AM; Barajas-Gamboa JS; Cheverie J; Jacobsen GR; Sandler BJ; Talamini MA; Bouvet M; Horgan S
    J Laparoendosc Adv Surg Tech A; 2014 Feb; 24(2):89-94. PubMed ID: 24401141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Surgical Resection of T1bN0 Esophageal Cancer and Assessment of Endoscopic Mucosal Resection for Identifying Low-Risk Cancers Appropriate for Endoscopic Therapy.
    Mohiuddin K; Dorer R; El Lakis MA; Hahn H; Speicher J; Hubka M; Low DE
    Ann Surg Oncol; 2016 Aug; 23(8):2673-8. PubMed ID: 27020584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
    Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.
    Spector R; Zheng Y; Yeap BY; Wee JO; Lebenthal A; Swanson SJ; Marchosky DE; Enzinger PC; Mamon HJ; Lerut A; Odze R; Srivastava A; Agoston AT; Tippayawang M; Bueno R;
    Semin Thorac Cardiovasc Surg; 2015; 27(2):205-15. PubMed ID: 26686448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
    Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival After Surgical Resection of Stage IV Esophageal Cancer.
    Saddoughi SA; Reinersman JM; Zhukov YO; Taswell J; Mara K; Harmsen SW; Blackmon SH; Cassivi SD; Nichols F; Shen KR; Wigle DA; Allen MS
    Ann Thorac Surg; 2017 Jan; 103(1):261-266. PubMed ID: 27623270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
    Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
    World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma.
    Lee PC; Mirza FM; Port JL; Stiles BM; Paul S; Christos P; Altorki NK
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1196-206. PubMed ID: 21397267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.